用素指导的生物活性类纳米药物具有级联转换,以改善对结肠癌的化疗
Can Wu1,2, Xiao Wei Zhang2,3, Manman Wang1
1School of Pharmacy, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Journal of nanobiotechnology
|January 31, 2025
概括
这项研究介绍了一种新的基于的纳米药物,可以增强结肠癌的化疗. 这种纳米药物使用素触发的级联转换来提高药物输送和疗效,从而导致瘤的切除.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 化疗对结肠癌至关重要,但面临着有限反应率的挑战.
- 生物活性提供了一种通过细胞内转化增强化疗活性的策略.
研究的目的:
- 开发一种对素敏感的生物活性基纳米药物,用于改善结肠癌化疗.
- 研究纳米药物的级联转化及其对药物保留和疗效的影响.
主要方法:
- 一个 (1-Pept) 与多克索鲁比辛 (Dox) 联合组装成纳米纤维 (1-Pept/Dox NFs).
- 调查细胞吸收机制 (洞穴介导的内细胞) 和细胞内贩运.
- 分析素诱导的转化 (1-Pept到Pept) 和随后的重组成更密集的纳米纤维 (Pept NF).
- 评估Pept NFs和Dox对细胞骨破坏,线粒体功能障碍和caspase-3激活等细胞过程的协同效应.
主要成果:
- 该纳米药物证明增强了细胞吸收和周核运输,避免了溶酶体降解.
- 素介导的1-Pept转化为Pept NFs诱导了显著的细胞损伤.
- 佩普特NFs和Dox的协同作用导致卡斯巴-3激活和核损伤增加,导致瘤切除.
结论:
- 开发的试素响应纳米药物显示了增强结肠癌化疗的希望.
- 纳米药物中的级联转换为提高治疗效率提供了一种新的策略.
- 这种方法代表了通过向药物输送和协同作用来打击结肠癌的新途径.
更多相关视频
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


